<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/257118-personal-care-compositions-containing-quaternary-ammonium-trihydroxy-substituted-dipropyl-ether by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 08:48:31 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 257118:PERSONAL CARE COMPOSITIONS CONTAINING QUATERNARY AMMONIUM TRIHYDROXY SUBSTITUTED DIPROPYL ETHER</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">PERSONAL CARE COMPOSITIONS CONTAINING QUATERNARY AMMONIUM TRIHYDROXY SUBSTITUTED DIPROPYL ETHER</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>A personal care composition is provided which includes a trihydroxy and quaternary ammonium substituted dipropyl ether. The substituted dipropyl ether functions as a humectant when applied to skin to moisturize both in high and low relative humidity environments.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>J9002/C<br>
FORM - 2<br>
THE PATENTS ACT, 1970<br>
(39 of 1970)<br>
&amp;<br>
The Patents Rules, 2003<br>
COMPLETE SPECIFICATION<br>
(See Section 10 and Rufe 13)<br><br><br>
PERSONAL CARE COMPOSITIONS CONTAINING QUATERNARY AMMONIUM TRIHYDROXY SUBSTITUTED DIPROPYL ETHER<br>
HINDUSTAN UNILEVER LIMITED, a company incorporated under the Indian Companies Act, 1913 and having its registered office at Hindustan Lever House, 165/166, Backbay Reclamation, Mumbai -400 020, Maharashtra, India<br><br><br><br>
The following specification particularly describes the invention and the manner in which it is to be performed<br><br>
WO 2007/101527<br><br>
PCT/EP2007/001297<br><br>
PERSONAL CARE COMPOSITIONS CONTAINING QUATERNARY AMMONIUM TRIHYDROXY SUBSTITUTED DIPROPYL ETHER<br>
BACKGROUND OF THE INVENTION<br>
5     The invention concerns personal care compositions providing moisturization both in high and low relative humidity environments.<br>
Dry skin is a problem in varying degree to most humans. This condition is particularly evident in<br>
winter.   Personal care products such as skin creams/lotions, shampoos/conditioners, toilette<br>
10     bars/shower gels and antiperspirant/deodorants are normally formulated with at least one<br>
material to address dry skin.   Symptoms such as itching, flaking and a visually displeasing<br>
' dermal appearance can all to some extend be modulated.<br>
There are three classes of materials employed against the problem. Oclusive such as 15 petrolatum or silicone oils serve to inhibit loss of natural moisture. They form a barrier between the epidermis and the environment Another approach is the use of keratofytic agents to enhance rate of dermal exfoliation. Alpha-hydroxy acids are the most common agents for achieving exfoliation.<br>
20 A third approach to dry skin is topical application of humectants. Hydroxylated monomeric and polymeric organic substances are generally used for this purpose. Glycerin known also as glycerol is one of the most effective humectants.<br>
There are several shortcomings in Hie performance of known humectants. Even the best such 25 as glycerin requires to be formulated at relatively high levels to achieve good moisturization. Secondly, known humectants perform well in high relative humidity environments; however, hardly any of these substances provide effectiveness at low relative humidity (i.e. less than 20% moisture at 20°C). Average indoor relative humidity during winter is approximately 13% in areas such as the Northeast U.S. It is quite evident that a real need exists for an improved 30     moisturization technology.<br>
A moisturizer known as Honeyquat 50 with INCI name of Hydroxypropyltrimonium Honey has been reported to be a better humectant than glycerin {see the Arch/Brooks brochure titled "Cosmetic Ingredients &amp; Ideas®", Issue No. 2, August 2001). Honeyquat 50 is described as 35 being derived from the reaction of pendent hydroxy! groups (on the disaccharide) of a "light" deodorized grade of honey with a chlorohydroxytrimethylammonium derivative.  Although this<br>
l<br><br>
WO 2007/101527<br><br>
PCT/EP2007/001297<br><br>
substance has excellent humectency, moisturization at low relative humidity still remains to be conquered.<br>
Accordingly, the present invention seeks to identify humectants which are operative not only at 5     high but also low relative humidity, for application in personal care products.<br>
SUMMARY OF THE INVENTION<br>
A personal care composition is provided which includes:<br>
(i)        from about 0.0000001 to about 10% by weight of a quatemized ammonium trihydroxy<br>
10	dipropyl ether selected from the group consisting of   formula   (I),   (I!)   and   mixtures<br>
thereof.<br><br>
wherein R is the same or different C1-3 alkyl or hydroxylalkyl group and X" is a cosmetically acceptable organic or inorganic anion; and<br>
5     (ii)       a cosmetically acceptable carrier.<br>
DETAILED DESCRIPTION OF THE INVENTION<br>
Now it has been found that dipropyl ethers substituted with a quaternary ammonium and three hydroxyl groups are excellent moisturizers providing humectancy in both high and low relative 0      humidity environments. These mono-ethers have the structural formula (I) and (II):<br><br>
wherein R is the same or different C1-3 alkyl or hydroxylalkyl group and X" is a cosmetically acceptable organic or inorganic anion.<br>
Ordinarily the C1-3alky! constituent on the quatemized ammonium group will be methyl, ethyl, n-<br>
25     propyl, isopropyl or hydroxyethyl and mixtures thereof.   Particularly preferred is a trimethyl<br>
ammonium group known through INCI nomenclature as a "trimonium" group. Any anion can be<br>
used in the quaternary ammonium salt. The anion may be organic or inorganic with the proviso<br>
2<br><br>
WO 2007/3 01527	PCT/EP2007;001297<br>
that the material is cosmetically acceptable. Typical inorganic anions are halides, sulfates, phosphates, nitrates and borates. Most preferred are the halides, especially chloride. Organic anionic counter ions include methosulfate, toluoyl sulfate, acetate, citrate, tartrate, lactate, gluconate and benzenesulfonate.<br>
Amounts of these dipropyl ethers may range from about 0.0000001 to about 10%, preferably from about 0.00001 to about 8%, more preferably from about 0.0001 to about 5%, still more preferably from about 0.001 to about 3%, even more preferably from about 0.1 to about 1% by weight of the composition.<br>
10<br>
Synthesis of the preferred dipropyl ethers (V) and (VI) is achieved by any of the synthetic methods described below:<br>
1)	reaction of 2,3-dihydroxypropyl trimethylammonium chloride (111) with 1-chloro-2,3-<br>
dihydroxypropane (IV) in the presence of aqueous sodium hydroxide (aq. NaOH)<br>
15	(Scheme I);<br>
2)	treatment of 2,3-dihydroxypropyl trimethylammonium chloride (III) with sodium hydride<br>
(NaH) in N,N-dimethylformamide (DMF) or 1-methyl-2-pyrrolidinone (NMP), followed by<br>
addition of 1-chloro-2,3-dihydroxypropane (IV) (Scheme II);<br>
3)	reaction of 2,3-dihydroxypropyl trimethylammonium chioride (111) with 4-chIoromethyl-<br>
20                2,2-dimethyl-1,3-dioxoIane (VII) in aqueous basic media, followed by acidification<br>
(Scheme III);<br>
4)	treatment of 2,2-dimethy1-4-hydroxymethy-1,3-dioxolane (VIII) with sodium hydride in<br>
N,N-dimethyiformamide or 1-methyl-2-pyrroIidinone, followed by addition of 1,3-<br>
dichloro-2-propanol (IX) and final addition of trimethylamine (X) (Scheme IV). The<br>
25	reaction schemes for the synthetic methods described above are shown below.<br>
Scheme<br><br>
3<br><br>
WO 2007/101527<br><br>
PCT/EP2007/001297<br><br>
Scheme II<br><br>
Thus, the present invention also provides new materials as identified by structures (V) and (VI)<br>
and a process of manufacture as reported above.  The process in its general form reacts 1-<br>
chloro-2,3-dihydroxypropane with 2,3-dihydroxypropyl-1-tri(C1-3) ammonium salt in a relative<br>
10     molar ratio ranging from about 3:1 to about 1:3, preferably about 1:1. The reaction is run in the<br>
4<br><br>
WO 2007/101527<br><br>
PCT/EP2007/001297<br><br>
presence of an alkali material which may be sodium hydroxide, potassium hydroxide, lithium hydroxide, calcium oxide, calcium hydroxide or sodium carbonate. The reaction can be run in a protic or an aprotic medium. Preferably the medium is protic, especially water. Nonetheless, other useful solvents include diethylether, tetrahydrofuran, ethanol, methanol, N,N-5 dimethylformamide, 1-methyf-2-pyrrolidinone and any mixtures thereof. Alternatively the reaction may be run neat without any solvent. Process temperatures may range from 5°C to 200°C, with preference given over the range 20°C to 50°C.<br>
Advantageously, compositions of the present invention may also include 2,3-dihydroxypropyl 10 tri(C1-3 alkyl or hydroxyalkyl) ammonium salts, the alkyl and salt corresponding to R and X of formula (I) and/or (II). Most preferred for the aforementioned non-ether quaternary ammonium salt is 2,3-dihydroxypropyl trimethyl ammonium chloride. When the dipropyl ether and non-ether quaternary ammonium salts are formulated together, they may be present in a weight ratio ranging from about 1:1 to about 1:10000, preferably from about 1:10 to about 1:5000, 15     more preferably from about 1:100 to about 1:1000.<br>
By the term personal care composition is meant any substance applied to a human body for improving appearance, cleansing, odor control or general aesthetics. Non-limiting examples of personal care compositions include leave-on skin lotions and creams, shampoos, hair 20 conditioners, shower gels, toilet bars, antiperspirants, deodorants, dental products, shave creams, depilatories, lipsticks, foundations, mascara, sunless tanners and sunscreen lotions.<br>
Compositions of this invention will also include a cosmetically acceptable carrier. Amounts of the earner may range from about 1 to about 99.9%, preferably from about 70 to about 95%,<br>
25 optimally from about 80 to about 90% by weight of the composition. Among the useful carriers are water, emollients, fatty acids, fatty alcohols, thickeners and combinations thereof. The carrier may be aqueous, anhydrous or an emulsion. Preferably the compositions are aqueous, especially water and oil emulsions of the W/O or O/W or triplex W/O/W variety. Water when present may be in amounts ranging from about 5 to about 95%, preferably from about 20 to<br>
30     about 70%, optimally from about 35 to about 60% by weight<br>
Emollient materials may serve as cosmetically acceptable carriers. These may be in the form of silicone oils, natural or synthetic esters and hydrocarbons. Amounts of the emollients may range anywhere from about 0.1 to about 95%, preferably between about 1 and about 50% by 35     weight of the composition.<br>
5<br><br>
WO 2007/101527<br><br>
PCTVEP2007/001297<br><br>
Silicone oils may be divided into the volatile and non-volatile variety.   The term "volatile" as used herein refers to those materials which have a measurable vapor pressure at ambient temperature. Volatile silicone oils are preferably chosen from cyclic (cyclomethicone) or linear polydimethylsiloxanes containing from 3 to 9, preferably from 4 to 5, silicon atoms. 5<br>
Non-volatile silicone oils useful as an emollient material include polyalkyl siloxanes, polyalkylaryl siloxanes and polyether siloxane copolymers. The essentially nonvolatile polyalkyl siloxanes useful herein include, for example, polydimethyl siloxanes with viscosities of from about 5 x 10"6 to 0.1 m2/s at 25°C. Among the preferred nonvolatile emollients useful in the 10 present compositions are the polydimethyl siloxanes having viscosities from about 1x10-5 to about 4x10-4m2/s at 25°C.<br>
Another class of non-voiatile silicones includes emulsifying and non-emulsifying silicone elastomers.   Representative of this category is dimethicone/vinyi dimethicone crosspolymer 15     (available as Dow Coming 9040, General Electric SFE 839, and Shin-Etsu KSG-18). Silicone waxes such as Siiwax WS-L (dimethicone copolyol laurate) may also be useful.<br>
Among the ester emollients are:<br>
20 a) Alky! esters of saturated fatty acids having 10 to 24 carbon atoms, eamptes of which include behenyl neopentanoate, isononyl isonanonoate, isopropyl myristate and octyl stearate;<br>
b)	Ether-esters such as fatty acid esters of ethoxylated saturated fatty alcohols;<br>
c)	Polyhydric alcohol esters, such as ethylene glycol mono and di-fatty acid esters, 25	diethylene glycol mono- and di-fatty acid esters, polyethylene glycol (200-6000) mono-<br>
and di-fatty acid esters, propylene glycol mono- and di-fatty acid esters, polypropylene<br>
glycol 2000 monostearate, ethoxylated propylene glycol monostearate, glyceryl mono-<br>
and di-fatty acid esters, polyglycerol poly-fatty esters, ethoxylated glyceryl mono¬<br>
stearate, 1,3-butylene glycol monostearate, 1,3-butylene glycol distearate,<br>
30	polyoxyethylene polyol fatty acid ester, sorb/tan fatty acid esters, and polyoxyethylene<br>
sorbitan fatty acid esters, in particular pentaerythritol, trimethylolpropane and neopentyl glycol esters of C1-C30 alcohols;<br>
d)	Wax esters such as beeswax, spermaceti wax and tribehenin wax; and<br>
e)	Sugar   ester   of   fatty   acids   such   as   sucrose   polybehenate   and   sucrose 35	polycottonseedate.<br>
6<br><br>
WO 2007/101527<br><br>
PCT/EP2007/001297<br><br>
Natural ester emollients principally are based upon mono-, di- and tri-glycerides. Representative glycerides include sunflower seed oil, cottonseed oil, borage oil, borage seed oil. primrose oil, castor and hydrogenated castor oils, rice bran oil, soybean oil, olive oil, safflower oil, shea butter, jojoba oil and combinations thereof. Animal derived emollients are 5 represented by lanolin oil and lanolin derivatives. Amounts of the natural esters may range from about 0.1 to about 20% by weight of the compositions.<br>
Hydrocarbons which are suitable cosmetically acceptable carriers include petrolatum, mineral oil, C11-C13 isoparaffins, polybutenes, and especially isohexadecane (available commercially as 10     Permethyl 101Afrom Presperse Inc).<br>
Fatty acids having from 10 to 30 carbon atoms may also be suitable as cosmetically acceptable earners.  Illustrative of this category are pelargonic, lauric, myristic, palmitic, stearic, isostearic, oleic, linoleic, linolenic, hydroxystearic and behenic acids. 15<br>
Fatty alcohols having from 10 to 30 carbon atoms are another useful category of cosmetically acceptable carrier. Illustrative of this category are stearyl alcohol, lauryl alcohol, myristyl alcohol, oleyl alcohol and cetyl alcohol.<br>
20 Thickeners can be utilized as part of the cosmetically acceptable carrier of compositions according to the present invention. Typical thickeners include crosslinked acrylates (e.g. Carbopol 982®), hydrophobic lly-modified acrylates (e.g. Carbopol 1382®), polyacrylamides (e.g. Sepigel 305®), acryloylmethylpropane sulfonic acid/salt polymers and copolymers (e.g. Aristoflex HMB® and AVC®), cellulosic derivatives and natural gums. Among useful cellulosic<br>
25 derivatives are sodium carboxymethylcellulose, hydroxypropyl methocellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, ethyl cellulose and hydroxymethyl cellulose. Natural gums suitable for the present invention include guar, xanthan, sclerotium, carrageenan, pectin and combinations of these gums. Inorganics may also be utilized as thickeners, particularly clays such as bentonftes and hectorites, fumed silicas, talc, calcium carbonate and silicates such as<br>
30 magnesium aluminum silicate (Veegum®). Amounts of the thickener may range from 0.0001 to 10%, usually from 0.001 to 1%, optimally from 0.01 to 0.5% by weight of the composition.<br>
Adjunct humectants may be employed in the present invention. These are generally polyhydric<br>
alcohol-type materials.     Typical polyhydric alcohols include glycerol, propylene glycol,<br>
35     dipropylene glycol, polypropylene glycol, polyethylene glycol, sorbitol, hydroxypropyl sorbitol,<br>
hexylene glycol, 1,3-butylene glycol, isoprene glycol, 1,2,6-hexanetriol, ethoxylated glycerol,<br>
7<br><br>
WO 2007/101527<br><br>
PCT/EP2007/001297<br><br>
propoxylated glycerol and mixtures thereof. The amount of adjunct humectant may range anywhere from 0.5 to 50%, preferably between 1 and 15% by weight of the composition.<br>
Personal care compositions of the present invention may be in any form.  These forms may 5     include lotions, creams, roll-on formulations, sticks, mousses, aerosol and non-aerosol sprays and fabric (e.g. non-woven textile) applied formulations.<br>
Surfactants may also be present in the compositions of the present invention. The total concentration of the surfactant when present may range from about 0.1 to about 90%,<br>
10 preferably from about 1 to about 40%, optimally from about 1 to about 20% by weight of the composition, and being highly dependent upon the type of personal care product. The surfactant may be selected from the group consisting of anionic, nonionic, cationic and amphoteric actives. Particularly preferred nonionic surfactants are those with a C10-20 fatty alcohol or acid hydrophobe condensed with from 2 to 100 moles of ethylene oxide or propylene<br>
15 oxide per mole of hydrophobe; C2-10 alkyl phenols condensed with from 2 to 20 moles of alkylene oxide; mono- and di-fatty acid esters of ethylene glycol; fatty acid monoglyceride; sorbitan, mono- and di- C8--20 fatty acids; and potyoxyethylene sorbitan as well as combinations thereof. Alkyl polyglycosides and saccharide fatty amides (e.g. methyl gluconamides) and trialkylamine oxides are also suitable nonionic surfactants.<br>
20<br>
Preferred anionic surfactants include soap, alky) ether sulfates and sulfonates, alkyl sulfates and sulfonates, alkylbenzene sulfonates, alkyl and dialkyl sulfosuccinates, C8-20 acyl isethionates, C8-20 alkyl ether phosphates, CB-20sarcosinates, CB-20acyl lactylates, sulfoacetates and combinations thereof.<br>
25<br>
Useful amphoteric surfactants include cocoamidopropyl betaine, G,2-2otriaIkyl betaines, sodium lauroamphoacetate and sodium laurodiamphoacetate.<br>
Sunscreen agents may also be included in compositions of the present invention. Particularly 30 preferred are such materials as ethylhexyl p-methoxycinnamate (available as Parsol MCX®), avobenzene (available as Parsol 1789®) and benzophenone-3 (also known as oxybenzone). Inorganic sunscreen actives may be employed such as microfine titanium dioxide and zinc oxide. Amounts of the sunscreen agents when present may generally range from 0.1 to 30%, preferably from 2 to 20%, optimally from 4 to 10% by weight of the composition. 35<br>
Antiperspirants and deodorant compositions of the present invention ordinarily will contain astringent actives.   Examples include aluminum chloride, aluminum chlorhydrex, aluminum-<br>
8<br><br>
WO 2007/101527<br><br>
PCT/EP2007/001297<br><br>
zirconium chlomydrex glycine, aluminum sulfate, zinc sulfate, zirconium and aluminum chlorohydroglycinate,   zirconium  hydroxychloride,  zirconium   and  aluminum  lactate,  zinc phenolsulfonate and combinations thereof.  Amounts of the astringents may range anywhere from about 0.5 to about 50% by weight of the composition. 5<br>
Dental products formulated according to the present invention will generally contain a fluoride source to prevent dental caries. Typical anti-caries actives include sodium fluoride, stannous fluoride and sodium monofluoro phosphate. Amounts of these materials will be determined by the amount of fluoride releasable which should range between about 500 to about 8800 ppm of 10 the composition. Other components of dentifrices can include desensitizing agents such as potassium nitrate and strontium nitrate, sweeteners such as sodium saccharine, aspartame, sucralose, and potassium acesulfam. Thickeners, opacifying agents, abrasives and colorants will normally also be present.<br>
15 Preservatives can desirably be incorporated into the personal care compositions of this invention to protect against the growth of potentially harmful microorganisms. Particularly preferred preservatives are phenoxyethanol, methyl paraben, propyl paraben, imidazolidinyl urea, dimethyloldimethylhydantoin, ethylenediaminetetraacetic acid salts (EDTA), sodium dehydroacetate, methylchloroisothiazolinone, methylisothiazolinone, iodopropynbutylcarbamate<br>
20 and benzyl alcohol. The preservatives should be selected having regard for the use of the composition and possible incompatibilities between the preservatives and other ingredients. Preservatives are preferably employed in amounts ranging from 0.01 % to 2% by weight of the composition.<br>
25 Compositions of the present invention may include vitamins. Illustrative vitamins are vitamin A (retinol), vitamin B2, vitamin B3 (niacinamide), vitamin B6, vitamin C, vitamin E, folic acid and biotin. Derivatives of the vitamins may also be employed. For instance, vitamin C derivatives include ascorbyl tetraisopalmitate, magnesium ascorbyl phosphate and ascorbyl glycoside. Derivatives of vitamin E include tocopheryl acetate, tocopheryl palmitate and tocopheryl<br>
30 linoleate. DL-pantheno! and derivatives may also be employed. For the purposes of this invention, vitamins where present are not considered as unsaturated materials. The total amount of vitamins when present in compositions according to the present invention may range from 0.001 to 10%, preferably from 0.01% to 1%, optimally from 0.1 to 0.5% by weight of the composition.<br>
9<br><br>
WO 2007/101527<br><br>
PCT/EP2007/001297<br><br>
Another type of useful substance can be that of an enzyme such as amylases, oxidases, proteases, lipases and combinations. Particularly preferred is superoxide dismutase (commercially available as Biocell SOD from the Brooks Company, USA).<br>
5 Skin lightening compounds may be included in the compositions of the invention. Illustrative substances are placental extract, lactic acid, niacinamide, arbutin, kojic acid, ferulic acid, resorcinol and derivatives including 4-substituted resorcinols and combinations thereof. Amounts of these agents may range from about 0.1 to about 10%, preferably from about 0.5 to about 2% by weight of the composition.<br>
10<br>
Desquamation promoters may be present Illustrative are the alpha-hydroxycarboxylic acids and beta-hydroxycarboxylic acids. The term "acid" is meant to include not only the free acid but also salts and C1-30 alkyl or aryl esters thereof and lactones generated from removal of water to form cyclic or linear lactone structures.   Representative acids are glycolic, lactic and malic<br>
15     acids. Salicylic acid is representative of the beta-hydroxycarboxylic acids. Amounts of these materials when present may range from about 0.01 to about 15% by weight of the composition. A variety of herbal extracts may optionally be included in compositions of this invention.   The extracts may either be water soluble or water-insoluble earned in a solvent which respectively is hydrophilic or hydrophobic. Water and ethanol are the preferred extract solvents.  Illustrative<br>
20 extracts include those from green tea, chamomile, licorice, aloe vera, grape seed, citrus unshui, willow bark, sage, thyme and rosemary.<br>
Also included may be such materials as lipoic acid, retinoxytrimethylsilane (available from Clariant Corp. under the Silcare 1M-75 trademark), dehydroepiandrosterone (DHEA) and 25 combinations thereof. Ceramides (including Ceramide 1, Ceramide 3, Ceramide 3B and Ceramide 6) as well as pseudoceramides may also be useful. Amounts of these materials may range from about 0.000001 to about 10%, preferably from about 0.0001 to about 1% by weight of the composition.<br>
30 Colorants, opacifiers and abrasives may also be included in compositions of the present invention. Each of these substances may range from about 0.05 to about 5%, preferably between 0.1 and 3% by weight of the composition.<br>
The compositions of the present invention can also be, optionally, incorporated into an insoluble 35     substrate for application to the skin such as in the form of a treated wipe.<br>
10<br><br>
WO 2007/101527<br><br>
PCT7EP2007/001297<br><br>
A wide variety of packaging can be employed to store and deliver the personal care compositions. Packaging is often dependent upon the type of personal care end-use. For instance, leave-on skin lotions and creams, shampoos, conditioners and shower gels generally employ plastic containers with an opening at a dispensing end covered by a closure. Typical 5 closures are screw-caps, non-aerosol pumps and flip-top hinged lids. Packaging for antiperspirants, deodorants and depilatories may involve a container with a roll-on ball on a dispensing end. Alternatively these types of personal care products may be delivered in a stick composition formulation in a container with propel-repel mechanism where the stick moves on a platform towards a dispensing orifice. Metallic cans pressurized by a propellant and having a 10 spray nozzle serve as packaging for antiperspirants, shave creams and other personal care products. Toilette bars may have packaging constituted by a cellulosic or plastic wrapper or within a cardboard box or even encompassed by a shrink wrap plastic film.<br>
The term "comprising" is meant not to be limiting to any subsequently stated elements but 15 rather to encompass non-specified elements of major or minor functional importance. In other words the listed steps, elements or options need not be exhaustive. Whenever the words "including" or "having" are used, these terms are meant to be equivalent to "comprising" as defined above.<br>
20 Except in the operating and comparative examples, or where otherwise explicitly indicated, all numbers in this description indicating amounts of material ought to be understood as modified by the word "about".<br>
Ail documents referred to herein, including all patents, patent applications, and printed 25     publications, are hereby incorporated by reference in their entirety in this disclosure.<br>
The following examples will more fully illustrate the embodiments of this invention. AH parts, percentages and proportions referred to herein and in the appended claims are by weight unless otherwise illustrated.<br>
30<br>
EXAMPLE 1a<br>
This example reports the synthesis of 1-trimethylammonium-2,5,6-trihydroxydipropyl ether chloride and 1-trimethylammonium-2-hydroxymethyl-4,5-dihydroxypropyl ethyl ether chloride. To a solution of 2,3-dihydroxypropyl trimethylammonium chloride (500mg, 2.95mmol) in<br>
35 aqueous sodium hydroxide (2.95ml, 2.95mmol) was added 1-chloro-2,3-dihydroxypropane (247uL, 2.95mmol). The resultant solution was stirred at room temperature until the pH decreased to 
11<br><br>
WO 2007/101527<br><br>
PCT/EP2007/001297<br><br>
reduced pressure at 50°C yielding a heterogeneous colorless syrup.   Filtration through glass wool affords  an  isomeric mixture of  1-trimethylammonium-2,5,6-trihydroxydipropyl ether chloride and 1-trimethylammonium-2-hydroxymethyl-4,5-dihydroxypropy1 ethyl ether chloride as a homogeneous syrup. 5<br>
EXAMPLE 1b<br>
This example reports the synthesis of 1-trimethylammonium-2,5,6-trihydroxydipropy1 ether chloride and 1-trimethylammoniun-2-ydroxymethyM1-4,5-dihydroxypropyl ethyl ether chloride. 2,3-Dihydroxypropyl trimethylammonium chloride (500mgt 2.95mmol) is added to a suspension<br>
10 of sodium hydride (2.95mmol) in N,N-dimethylformamide or 1-methyl-2-pyrrolidone (3-10ml) and the resulting mixture stirred at room temperature until gas evolution ceases. This mixture is then added to 1-chloro-2,3-dihydroxypropane (247ul_, 2.95mmol) and the resultant mixture stirred at room temperature until the pH decreases to 
15 ether. Removal of the water under reduced pressure at 50°C, followed by filtration through glass wool affords an isomeric mixture of 1-trimethyiammonium-2,5,6-trihydroxydipropyl ether chloride and 1-trimethylammonium-2-hydroxymethyl-4,5-dihydroxypropyl ethyl ether chloride as a homogeneous syrup.<br>
20      EXAMPLE 1c<br>
This example reports the synthesis of 1-trimethylammonium-2,5,6- trihydroxydipropyl ether chloride and 1-trimethy1ammonium-2-hydroxymethyI-4l5-dihydroxypropyl ethyl ether chloride. To a solution of 2,3-dihydroxypropyl trimethylammonium chloride (500mg, 2.95mmol) in aqueous sodium hydroxide (2.95ml, 2.95mmol) is added 4-chloromethyl-2l2-dimethyl-1,3-<br>
25 dioxolane (418ul, 2.95mmol). The resultant solution is stirred at room temperature until the pH decreases to 
30 trimethylammonium-2-hydroxymethyW,5-dihydroxypropyl ethyl ether chloride as a homogeneous syrup.<br>
EXAMPLE 1d<br>
This example reports the synthesis of 1-trimethylammonium-2,5,6-trihydroxydipropyi ether<br>
35     chloride.   2,2-Dimethyl-4-hydroxymethy1-1,3-dioxoIane   (367ul,   2.95mmol)   is   added   to  a<br>
suspension of sodium hydride (2.95mmol) in N.N-dimethylformamide or 1-methyl-2-pyrrolidone<br>
12<br><br>
WO 2007/101527<br><br>
PCT/EP2007/001297<br><br>
(3-10ml) and the resulting mixture stirred at room temperature until gas evolution ceases. This mixture is then added to 1,3-chtoro-2-propanol (281 uL, 2.95mmol) and the resultant mixture stirred at room temperature until the pH decreases to 
EXAMPLE 2 10     A representative personal care composttion of the present invention in the form of a cosmetic lotion is outlined under table I.'<br>
TABLE I<br><br>
INGREDIENT	WEIGHT %<br>
PHASE A<br>
Water	Balance<br>
Disodium EDTA	0.05<br>
Methyl paraben	0.15<br>
Magnesium aluminum silicate	0.60<br>
Triethanolamine	1.20<br>
Quatemized ammonium trihydroxy dipropylether salt of example 1c	1.00<br>
PHASEB<br>
Xanthan gum	0.20<br>
NatrosoI®250HHR (ethyl cellulose)	0.50<br>
Butyfene glycol	3.00<br>
Glycerin	2.00<br>
PHASEC<br>
Sodium stearoyl lactylate	0.10<br>
Glycerol monostearate	1.50<br>
Stearyl alcohol	1.50<br>
Isostearyl palmitate	3.00<br>
Silicone fluid	1.00<br>
Cholesterol	0.25<br>
Sorbitan stea rate	1.00<br>
Butylated hydroxy toluene	0.05<br>
Vitamin E acetate	0.01<br>
13<br><br>
WO 2007/101527	PCT/EP2007/001297<br><br>
PEG-100stearate	2.00<br>
Stearic acid	3.00<br>
Propyl paraben	0.10<br>
Parsol MCX®	2.00<br>
Caprylic/capric triglyceride	0.50<br>
Hydroxycaprylic acid	0.01<br>
C12-15 Alkyl octanoate	3.00<br>
PHASED<br>
Vitamin A palmitate	0.10<br>
Bisabolol	0.01<br>
Vitamin A acetate	0.01<br>
Fragrance	0.03<br>
Retinol 50C	0.02<br>
Conjugated linoieic acid	0.50<br>
EXAMPLE 3<br>
A water-in-oil topical liquid make-up foundation according to invention is described in table II<br>
below.<br>
TABLE II<br><br>
INGREDIENT	WEIGHT %<br>
PHASE A	<br>
Cyclomethicone	9.25<br>
Oleyl oleate	2.00<br>
Dimethicone copolyol	20.00<br>
PHASE B	<br>
Talc	3.38<br>
Pigment (iron oxides)	10.51<br>
Spheron L-1500 (silica)	0.50<br>
PHASEC	<br>
Synthetic wax Durachem 0602	0.10<br>
Arachidyl behenate	0.30<br>
PHASE D	<br>
Cyclomethicone	1.00<br>
Trihydroxystearin	0.30<br>
14<br><br>
WO 2007/101527<br><br>
PCT/EP20O7/0O1297<br><br><br>
Quatemized ammonium trihydroxy dipropylether salt of example 1a	0.10<br>
Disodium EDTA	0.10<br>
Glydant Plus"	0.10<br>
PEG-100stearate	0.10<br>
Stearic acid	0.10<br>
Purified water	Balance<br>
Isohexadecane (Presperse Incorporated, South PJainfield, NJ)<br>
2	Polyacrylamide and C13-14 isoparaffin and Laureth-7 (Seppic Corporation, Fairfield. NJ)<br>
3	Dimethicone and dimethiconol (Dow Coming Corporation, Midland, Ml)<br>
4	Sorbitan monostearate and sucrococoate (ICI Americas Incorporated, Wilmington, DE)<br>
5	Sucrose ester of fatty add<br>
6	DMDM hydantoin and iodopropynyl butylcarbamate (Lonza Incorporated, Fairiawn, NJ)<br><br>
10<br><br>
EXAMPLE 5<br>
Illustrative of another cosmetic composition incorporating a dipropyl ether salt according to the present invention is the formula of table IV.<br><br>
TABLE IV<br><br>
INGREDIENT	WEIGHT %<br>
Polysilicone-11	29<br>
Cyclomethicone	59<br>
Petrolatum	11<br>
Quatemized ammonium trihydroxy dipropylether salt of example 1a	0.2<br>
Dimethicone copolyol	0.3<br>
Sunflowerseed oil	0.5<br>
EXAMPLE 6<br>
15     A relatively anhydrous composition incorporating a dipropyl ether salt of the present invention is reported in table V.<br>
TABLE V<br><br>
INGREDIENT	WEIGHT %<br>
Cyclomethicone	80.65<br>
Dimethicone	9.60<br>
Squalane	6.00<br>
I so stearic acid	1.90<br>
16<br><br>
WO 2007/101527	PCT/EP2007/001297<br><br>
Borage seed oil	0.90<br>
Quatemized ammonium trihydroxy dipropylether salt of example 1 b	0.50<br>
Retiny! palmitate	0.25<br>
Ceramide 6	0.10<br>
Tocopherol	0.10<br>
EXAMPLE 7<br>
An aerosol packaged foaming cleanser with a dipropyl ether salt suitable for the present<br>
invention is outlined in table VI.<br>
TABLE VI<br><br>
INGREDIENT	WEIGHT %<br>
Sunflower seed oil	20.00<br>
Maleated soybean oil	5.00<br>
Silicone urethane	1.00<br>
PoIyglycero-4 oleate	1.00<br>
Sodium C14-16 olefin sulfonate	15.00<br>
Sodium lauryl ether sulphate (25% active)	15.00<br>
Cocoamidopropylbetaine	15.00<br>
DC 1784® (silicone emulsion 50%)	5.00<br>
Polyquatemium-11	1.00<br>
Quatemized ammonium trihydroxy dipropylether satt of example 1 b	1.00<br>
Water	Balance<br>
EXAMPLE 8<br>
A disposable, single use personal care towelette product is described according to the present 10     invention. A 70/30 polyester/rayon non-woven towelette is prepared with a weight of 1.8 grams and dimensions of 15 cm by 20 cm. Onto this towelette is impregnated a composition with a dipropyl ether salt as outlined in table Vll below.<br>
TABLE VII<br><br>
INGREDIENT	WEIGHT %<br>
2,3-Dihydroxy trimethyl ammonium chloride	5.00<br>
Glycerin	2.00<br>
Hexylene glycol	2.00<br>
Disodium capryl amphodiacetate	1.00<br>
17<br><br>
WO 2007/101527	PCT/EP2007/001297<br><br>
Gluconolactone	0.90<br>
Silicone microemulsion	0.85<br>
Witch hazel	0.50<br>
PEG-40 hydrogenated castor oil	0.50<br>
Fragrance (terpenoid mixture)	0.20<br>
Quatemized ammonium trihydroxy dipropylether salt of example 1c	0.05<br>
Vitamin E acetate	0.001<br>
Water	Balance<br>
EXAMPLE 9<br>
A toilette bar illustrative of the present invention is outlined under table Vlll.<br>
5     TABLE Vlll<br><br>
INGREDIENT	WEIGHT %<br>
Sodium Soap (85/15 tallow/coconut)	77.77<br>
Quatemized ammonium trihydroxy dipropylether salt of example 1a	3.50<br>
Glycerin	2.50<br>
Sodium chloride	0.77<br>
Titanium dioxide	0.40<br>
Fragrance	1.50<br>
Disodium EDTA	0.02<br>
Sodium etidronate	0.02<br>
Fluorescer	0.024<br>
Water	Balance<br>
EXAMPLE 10<br>
A shampoo composition useful in the context of the present invention is described in table IX below.<br>
TABLE IX<br><br>
Ingredient	Weight %<br>
Ammonium laureth sulfate	12.00<br>
Ammonium lauryl sulfate	2.00<br>
Cocoa midopropyl betaine	2.00<br>
Sodium lauroamphoacetate	2.00<br>
2,3-Dihydroxypropy! trimethyl ammonium chloride	1.50<br>
18<br><br>
WO 2007/101527	PCT/EP2007/001297<br><br>
Ethylene glycol distearate	1.50<br>
Cocomonoethanolamide	0.80<br>
Cetyl alcohol	0.60<br>
Polyquatemium-10	O.50<br>
Quatemized ammonium trihydroxy dipropylether salt of example 1a	0.50<br>
Dimethicone	1.00<br>
Zinc pyridinethione	1.00<br>
Sodium citrate	0.40<br>
Citric acid	0.39<br>
Sodium xylene sulfonate	1.00<br>
Fragrance	0.40<br>
Sodium benzoate	0.25<br>
Kathon CG®	0.0008<br>
Benzyl alcohol	0.0225<br>
Water	Balance<br>
EXAMPLE 11<br>
This example illustrates an antiperspirant/deodorant formula incorporating the moisturizing<br>
actives according to the present invention.<br><br>
TABLEX		<br>
Ingredient		Weight %<br>
Cyclopentacycloxane		44<br>
Dimethicone		20<br>
Aluminum zirconium trichlorohydrex	glycinate	15<br>
Quatemized ammonium trihydroxy dipropylether salt of example 1 c	5.0<br>
C18-C36 acid triglyceride		5.0<br>
Microcrystalline wax		3.0<br>
Glycerin		3.0<br>
Silica		2.5<br>
Dimethicone crosspolyrner		1.0<br>
Fragrance		0.5<br>
Disodium EDTA		0.4<br>
Butylated hydroxytoluene		0.3<br>
Citric acid		0.3<br>
19<br><br>
WO 2007/101527<br><br>
PCT/EP2007/001297<br><br>
EXAMPLE 12<br>
A toothpaste according to the present invention can be formulated with the ingredients listed under table XI.<br><br>
TABLE XI		<br>
Ingredients		Weight %<br>
Zeodent115®		20.00<br>
Glycerin		18.00<br>
Xanthan gum		7,00<br>
Sodium carboxymethyl cellulose	0.50<br>
Sodium bicarbonate		2.50<br>
Quatemized ammonium	trihydroxy dipropylether salt of example 1 a	2.00<br>
Sodium laurylsulfate		1.50<br>
Sodium fluoride		1.10<br>
Sodium saccharin		0.40<br>
Titanium dioxide		1.00<br>
PluronicF-127®		2.00<br>
FD&amp;CblueNo. 1		3.30<br>
Menthol		0.80<br>
Potassium nitrate		5.00<br>
Water		balance<br>
EXAMPLE 13<br>
A moisturizing oil-in-water lotion can be formulated with the ingredients listed under table XII.<br>
10     TABLE XII<br><br>
INGREDIENT	WEIGHT %<br>
Water	Balance<br>
Quaternary ammonium trihydroxydipropylether salt of example 1 c	0.5<br>
Glycerin	5.00<br>
Disodium EDTA	0.1<br>
Methyl paraben	0.1<br>
Niacinamide	0.5<br>
Triethanoiamine	0.25<br>
D-Pantheno!	0.1<br>
Sodium dehydroacetate	0.1<br>
20<br><br>
WO 2007/101527<br><br>
PCT/EP20O7/OO1297<br><br><br>
Benzyl alcohol	0.25<br>
GLW75CAP-MP1	0.5<br>
Hexamidine disethionate	0.1<br>
Palmitoyl-penta peptide2	0.0003<br>
N-Acetyl glucosamine	1.0<br>
Soy isoflavone	0.5<br>
Isohexadecane	3.0<br>
Isopropyl isostearate	0.5<br>
Cetyl alcohol	0.3<br>
Stearyl alcohol	0.35<br>
Behenyl alcohol	0.3<br>
PEG-100stearate	0.1<br>
Cetearyl glucoside	0.1<br>
Sodium acrylate/sodium acryloyldimethyi taurate copolymer/isohexadecane/Polysorbate 80	3.0<br>
Dimethicone/dimethiconol	1.0<br>
Polymethylsilsequioxane	0.5<br>
Timiron Splendid Red3	1.0<br>
75% aqueous titanium dioxide dispersion (available from Kobo).<br>
2	Palmitoyi-lysine-threonine-threonine-lysine-serine (available from SedermaX<br>
3	Sifica and titanium dioxide coated mica red interference pigment (available from Rona).<br>
5      EXAMPLE 14<br>
Illustrated herein is a moisturizing water-in-silicone cream/lotion formulated with the ingredients listed under table XIII<br>
TABLE Xitl<br><br>
INGREDIENT	WEIGHT %<br>
Water	Balance<br>
Quaternary ammonium trihydroxydipropylethersalt of example 1a	0.5<br>
Allantoin	0.2<br>
Disodium EDTA	0.1<br>
Ethyl paraben	0.2<br>
Propyl paraben	0.1<br>
Caffeine	1.0<br>
BHT	0.1<br>
21<br><br>
WO 2007/101527	PCT/EP2007/001297<br><br>
Dexpanthenol	0.5<br>
Glycerin	10.0<br>
Niacinamide	2.0<br>
Palmitoyl-pentapeptide1	0.0003<br>
GLW75CAP-MP2	0.5<br>
Tlmiron Splendid Red3	1.0<br>
Palmitoyl-lysine-threonine-threonine-lysine-serine (available from Sederma).<br>
2	75% aqueous titanium dioxide dispersion (available from Kobo).<br>
3	Silica and titanium dioxide coated mica red interference pigment (available from Rona).<br>
22<br><br>
WO 2007/101527	PCT/EP2007/001297<br>
CLAIMS<br>
1.	A personal care composition comprising:<br>
(i)        from 0.0000001 to 10% by weight of a quatemized ammonium trihydroxy<br>
5	dipropyl ether selected from the group consisting of formula (I), (II) and mixtures<br>
thereof<br>
wherein R is the same or different C13 alkyl or hydroxylalkyl group and X" is a cosmetically acceptable organic or inorganic anion; and<br><br>
wherein R is the same or different C1-3 alkyl or hydroxylalkyl group and X" is a cosmetically acceptable organic or inorganic anion; and<br>
10	(ii)       a cosmetically acceptable earner.<br>
2.	The composition according to claim 1 wherein R is a methyl group.<br>
3.	The composition according to claim 1 wherein X* is chloride. 15<br>
4.	The composition according to claim 1  further comprising a 2,3-dihydroxypropyl<br>
trifC1-C3) quaternary ammonium salt.<br>
5.	The composition according to claim 4 wherein the ratio of quatemized ammonium<br>
20                trihydroxy dipropylether to 2,3-dihydroxypropyl trifCrQj) quaternary ammonium salt<br>
ranges from 1; 1 to about 1:10,000 by weight.<br>
6.	The composition according to claim 5 wherein the ratio ranges from about 1:10 to<br>
about 1:5000 by weight<br>
25<br>
7.	The composition according to claim 5 wherein the ratio ranges from about 1:100 to<br>
about 1:1000.<br>
8.	The composition according to claim 4 wherein  the 2,3-dihydroxypropyl tri(C1-C3) 30	quaternary ammonium salt is 2,3-dihydroxypropyl trimethylarnmoniurn chloride.<br>
9.	A compound having the formula (I) or (II)<br>
23<br><br>
WO 2007/101527<br><br>
PCT/EP2007/001297<br><br><br><br><br><br>
wherein R is the same or different C1-C3 alkyl or hydraxylalkyl group and X" is a cosmetically acceptable organic or inorganic anion.<br>
10.       A compound according to claim 9 wherein R is methyl and X" is chloride.<br><br><br>
HINDUSTAN UNILEVER LIMITED<br>
Dated this 28th day of August 2008<br></td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1tdW1ucC0yMDA4IGNsYWltcy5wZGY=" target="_blank" style="word-wrap:break-word;">1856-mumnp-2008 claims.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUFOTkVYVVJFIFRPIEZPUk0gMygyMC0xMC0yMDA4KS5wZGY=" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-ANNEXURE TO FORM 3(20-10-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUFTU0lHTk1FTlQoMjgtOC0yMDA4KS5wZGY=" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-ASSIGNMENT(28-8-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUNMQUlNUygyOC04LTIwMDgpLnBkZg==" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-CLAIMS(28-8-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUNMQUlNUyhBTUVOREVEKS0oMjItNy0yMDEzKS5wZGY=" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-CLAIMS(AMENDED)-(22-7-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUNMQUlNUyhBTUVOREVEKS0oMzEtNy0yMDEzKS5wZGY=" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-CLAIMS(AMENDED)-(31-7-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUNMQUlNUyhNQVJLRUQgQ09QWSktKDIyLTctMjAxMykucGRm" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-CLAIMS(MARKED COPY)-(22-7-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUNMQUlNUyhNQVJLRUQgQ09QWSktKDMxLTctMjAxMykucGRm" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-CLAIMS(MARKED COPY)-(31-7-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1tdW1ucC0yMDA4LWNsYWltcy5kb2M=" target="_blank" style="word-wrap:break-word;">1856-mumnp-2008-claims.doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1tdW1ucC0yMDA4LWNvcnJlc3BvbmRhbmNlLnBkZg==" target="_blank" style="word-wrap:break-word;">1856-mumnp-2008-correspondance.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUNPUlJFU1BPTkRFTkNFKDEwLTYtMjAxMykucGRm" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-CORRESPONDENCE(10-6-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUNPUlJFU1BPTkRFTkNFKDExLTEtMjAxMykucGRm" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-CORRESPONDENCE(11-1-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUNPUlJFU1BPTkRFTkNFKDIwLTEwLTIwMDgpLnBkZg==" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-CORRESPONDENCE(20-10-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUNPUlJFU1BPTkRFTkNFKDI3LTExLTIwMDkpLnBkZg==" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-CORRESPONDENCE(27-11-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUNPUlJFU1BPTkRFTkNFKDI4LTgtMjAwOCkucGRm" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-CORRESPONDENCE(28-8-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUNPUlJFU1BPTkRFTkNFKDMtMTItMjAxMikucGRm" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-CORRESPONDENCE(3-12-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUNPUlJFU1BPTkRFTkNFKDMxLTctMjAxMykucGRm" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-CORRESPONDENCE(31-7-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUNPUlJFU1BPTkRFTkNFKDktNi0yMDEwKS5wZGY=" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-CORRESPONDENCE(9-6-2010).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LURFU0NSSVBUSU9OKENPTVBMRVRFKS0oMjgtOC0yMDA4KS5wZGY=" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-DESCRIPTION(COMPLETE)-(28-8-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1tdW1ucC0yMDA4LWRlc2NyaXB0aW9uKGNvbXBsZXRlKS5kb2M=" target="_blank" style="word-wrap:break-word;">1856-mumnp-2008-description(complete).doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1tdW1ucC0yMDA4LWRlc2NyaXB0aW9uKGNvbXBsZXRlKS5wZGY=" target="_blank" style="word-wrap:break-word;">1856-mumnp-2008-description(complete).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUVYQU1JTkFUSU9OIFJFUE9SVCBSRVBMWSgyNi0zLTIwMTIpLnBkZg==" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-EXAMINATION REPORT REPLY(26-3-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUZPUkVJR04gRklMSU5HUyBDT1JSRVNQT05ERU5DRSgyMC0xMC0yMDA4KS5wZGY=" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-FOREIGN FILINGS CORRESPONDENCE(20-10-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1tdW1ucC0yMDA4LWZvcm0gMS5wZGY=" target="_blank" style="word-wrap:break-word;">1856-mumnp-2008-form 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUZPUk0gMTMoNy0yLTIwMTIpLnBkZg==" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-FORM 13(7-2-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUZPUk0gMTgoMjctMTEtMjAwOSkucGRm" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-FORM 18(27-11-2009).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUZPUk0gMihDT01QTEVURSktKDI4LTgtMjAwOCkucGRm" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-FORM 2(COMPLETE)-(28-8-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUZPUk0gMihUSVRMRSBQQUdFKS0oMjgtOC0yMDA4KS5wZGY=" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-FORM 2(TITLE PAGE)-(28-8-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1tdW1ucC0yMDA4LWZvcm0gMih0aXRsZSBwYWdlKS5wZGY=" target="_blank" style="word-wrap:break-word;">1856-mumnp-2008-form 2(title page).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1tdW1ucC0yMDA4LWZvcm0gMi5kb2M=" target="_blank" style="word-wrap:break-word;">1856-mumnp-2008-form 2.doc</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1tdW1ucC0yMDA4LWZvcm0gMi5wZGY=" target="_blank" style="word-wrap:break-word;">1856-mumnp-2008-form 2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUZPUk0gMygxMi04LTIwMTEpLnBkZg==" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-FORM 3(12-8-2011).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUZPUk0gMygxNS0yLTIwMTEpLnBkZg==" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-FORM 3(15-2-2011).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUZPUk0gMygxNS0yLTIwMTIpLnBkZg==" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-FORM 3(15-2-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUZPUk0gMygyMi02LTIwMTMpLnBkZg==" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-FORM 3(22-6-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUZPUk0gMygyMy0xLTIwMTMpLnBkZg==" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-FORM 3(23-1-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUZPUk0gMygyNC0yLTIwMTApLnBkZg==" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-FORM 3(24-2-2010).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUZPUk0gMygyNi0zLTIwMTIpLnBkZg==" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-FORM 3(26-3-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUZPUk0gMygyOC04LTIwMDgpLnBkZg==" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-FORM 3(28-8-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUZPUk0gMyg0LTgtMjAxMCkucGRm" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-FORM 3(4-8-2010).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUZPUk0gMyg4LTgtMjAxMikucGRm" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-FORM 3(8-8-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1tdW1ucC0yMDA4LWZvcm0gMy5wZGY=" target="_blank" style="word-wrap:break-word;">1856-mumnp-2008-form 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1tdW1ucC0yMDA4LWZvcm0gNS4ucGRm" target="_blank" style="word-wrap:break-word;">1856-mumnp-2008-form 5..pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1tdW1ucC0yMDA4LWZvcm0gcGN0IGlzYSAyMTAucGRm" target="_blank" style="word-wrap:break-word;">1856-mumnp-2008-form pct isa 210.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1tdW1ucC0yMDA4LWZvcm0gcGN0LWlwZWEtNDE2LnBkZg==" target="_blank" style="word-wrap:break-word;">1856-mumnp-2008-form pct-ipea-416.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1tdW1ucC0yMDA4LWZvcm0tcGN0LWlwZWEtNDA5LnBkZg==" target="_blank" style="word-wrap:break-word;">1856-mumnp-2008-form-pct-ipea-409.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LUdFTkVSQUwgUE9XRVIgT0YgQVRUT1JORVkoMjgtOC0yMDA4KS5wZGY=" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-GENERAL POWER OF ATTORNEY(28-8-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LU9USEVSIERPQ1VNRU5UKDIwLTEwLTIwMDgpLnBkZg==" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-OTHER DOCUMENT(20-10-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LU9USEVSIERPQ1VNRU5UKDIyLTctMjAxMykucGRm" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-OTHER DOCUMENT(22-7-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LVBFVElUSU9OIFVOREVSIFJVTEUtMTM3KDIyLTctMjAxMykucGRm" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-PETITION UNDER RULE-137(22-7-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LVBPV0VSIE9GIEFUVE9STkVZKDIyLTctMjAxMykucGRm" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-POWER OF ATTORNEY(22-7-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1tdW1ucC0yMDA4LXBvd2VyIG9mIGF0dG9ybmV5LnBkZg==" target="_blank" style="word-wrap:break-word;">1856-mumnp-2008-power of attorney.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LVJFUExZIFRPIEVYQU1JTkFUSU9OIFJFUE9SVCgzLTUtMjAxMikucGRm" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-REPLY TO EXAMINATION REPORT(3-5-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LVJFUExZIFRPIEhFQVJJTkcoMjItNy0yMDEzKS5wZGY=" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-REPLY TO HEARING(22-7-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1NVU1OUC0yMDA4LVVTIERPQ1VNRU5UUygyNi0zLTIwMTIpLnBkZg==" target="_blank" style="word-wrap:break-word;">1856-MUMNP-2008-US DOCUMENTS(26-3-2012).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTg1Ni1tdW1ucC0yMDA4LXdvLWludGVybmF0aW9uYWwgcHVibGljYXRpb24gcmVwb3J0IGExLnBkZg==" target="_blank" style="word-wrap:break-word;">1856-mumnp-2008-wo-international publication report a1.pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="257117-process-for-producing-spherical-base-granule-comprising-easily-water-soluble-drug.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="257119-surface-modified-bi-component-polymeric-fiber.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>257118</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>1856/MUMNP/2008</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>36/2013</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>06-Sep-2013</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>04-Sep-2013</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>28-Aug-2008</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>HINDUSTAN UNILEVER LIMITED</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>HINDUSTAN UNILEVER LIMITED, UNILEVER HOUSE, B.D. SAWANT MARG, CHAKALA, ANDHERI EAST, MUMBAI -400 099</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>HARICHIAN BIJAN</td>
											<td>UNILEVER HOME &amp; PERSONAL CARE USA, 40 MERRITT BOULEVARD, TRUMBULL, CONNECTICUT 06611.</td>
										</tr>
										<tr>
											<td>2</td>
											<td>ROSA JOSE GUILLERMO</td>
											<td>UNILEVER HOME &amp; PERSONAL CARE USA, 40 MERRITT BOULEVARD, TRUMBULL, CONNECTICUT 06611.</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>A61K8/41</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/EP2007/001297</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2007-02-13</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>60/779858</td>
									<td>2006-03-07</td>
								    <td>U.S.A.</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/257118-personal-care-compositions-containing-quaternary-ammonium-trihydroxy-substituted-dipropyl-ether by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 08:48:32 GMT -->
</html>
